$86.8M
11-50
Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases.
City Rank
Share
2nd
In Waltham
out of 3 exits
National Rank
Share
42nd
In United States
out of 194 exits
Regional Rank
Share
45th
In North America
out of 204 exits
City Rank
Share
1st
In Waltham
out of 2 exits
National Rank
Share
26th
In United States
out of 124 exits
Regional Rank
Share
27th
In North America
out of 129 exits
Exit Explorer
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...